Bank of Montreal
TLSI icon

Bank of Montreal’s TriSalus Life Sciences TLSI Stock Holding History

Bank of Montreal’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-781,803
Closed -$7.78K – 4278
2022
Q3 		$7.78K Buy
781,803
+4,782
+0.6% +$47.3K ﹤0.01% 1118
2022
Q2 		$7.65K Buy
+777,021
New +$7.64M ﹤0.01% 1183

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal's TLSI Position: Q4 2022 in Review

Bank of Montreal sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 781,803 shares — an estimated $7.78K sold.

Bank of Montreal first reported a position in TLSI in Q2 2022 and held it in 2 quarters. The position peaked at $7.78K in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Bank of Montreal reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 781,803 TriSalus Life Sciences shares in Q4 2022, an estimated $7.78K.
  • Bank of Montreal first reported a position in TriSalus Life Sciences in Q2 2022 and held it in 2 quarters.
  • Bank of Montreal's TriSalus Life Sciences position peaked at $7.78K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.